DALLAS, Nov. 20, 2024 /PRNewswire/ — On Point Legal Leads, a leading provider of mass tort leads and signed intake retainers, is excited to announce the launch of its latest comprehensive guide, Depo-Provera: Litigation Controversial Safety Warnings.
This in-depth analysis sheds light on the critical health and legal issues surrounding Depo-Provera, empowering legal professionals, patients, and industry stakeholders with essential information.
The guide provides extensive insights into:
- The health risks associated with Depo-Provera, including a significant increase in meningioma risk as highlighted by recent studies.
- Disparities in Pfizer’s international safety warnings, including meningioma risk information provided in Europe and Canada but not in the U.S.
- The expected scope of litigation, with projections for Multidistrict Litigation (MDL) in 2025 involving an estimated 30,000 cases.
Key findings from the guide include:
- Depo-Provera users are 5.55 times more likely to develop meningiomas than non-users, according to a 2024 British Medical Journal study.
- Since its FDA approval in 1992, Depo-Provera has been used by over a quarter of sexually active women in the U.S., underscoring its widespread reach.
- Ongoing legal cases focus on Pfizer’s alleged failure to warn U.S. consumers of the risks, despite having issued warnings in other countries.
Robert Wilson, President and Founder of On Point Legal Leads, commented on the urgency of the issue: “As we uncover more about the health impacts of Depo-Provera, it’s crucial that affected individuals have access to accurate information and strong legal representation. This guide is a valuable resource for those seeking justice and transparency in their healthcare options.”
The report also explores the potential long-term effects and substantial medical costs faced by those diagnosed with meningiomas after using Depo-Provera, underscoring the need for heightened awareness and proactive legal support.
Emerging Legal and Healthcare Trends
The guide provides a forward-looking perspective on trends shaping the future of Depo-Provera litigation, including:
- Anticipated expansion in litigation, as legal experts project a substantial increase in cases over the next year.
- The importance of transparent safety communications and accountability in the pharmaceutical industry.
- Steps for current and former Depo-Provera users to assess their health risks and protect their legal rights.
“At On Point Legal Leads, we’re committed to advancing access to critical information and facilitating legal connections for those impacted by Depo-Provera,” Mr. Wilson added. “This guide is part of our ongoing mission to support law firms in meaningful, impactful ways as they navigate this complex area of mass tort litigation.”
Access the Full Guide on Depo-Provera and Learn More
The complete guide, Depo-Provera Litigation: Controversial Safety Warnings, is available now on the On Point Legal Leads website.
For additional information on Depo-Provera mass tort leads and signed retainers, please visit: https://onpointlegalleads.com/mass-tort-leads/depo-provera-litigation-controversial-safety-warnings/
About On Point Legal Leads:
Founded in 2016, On Point Legal Leads is a trusted provider of high-quality legal leads and intake services across the United States. Specializing in mass torts, personal injury, workers’ compensation, and more, On Point Legal Leads delivers targeted, real-time leads to help law firms connect with clients seeking legal representation.
For more information, visit: https://onpointlegalleads.com/
Media Contact:
Robert Wilson
9723335114
SOURCE On Point Legal Leads
WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In